Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 40
Filtrar
Más filtros

País/Región como asunto
País de afiliación
Intervalo de año de publicación
1.
Food Funct ; 8(7): 2500-2511, 2017 Jul 19.
Artículo en Inglés | MEDLINE | ID: mdl-28640317

RESUMEN

Helicobacter pylori infection is marked by intense production of reactive oxygen species (ROS) through the activation of neutrophils that are constantly attracted to the infected gastric mucosa. Here, gallic acid and its alkyl esters were evaluated as compounds able to act as antimicrobial agents and inhibitors of ROS released by H. pylori-activated neutrophils simultaneously. We found that the higher hydrophobicity caused by esterification of gallic acid led to a significant increase in its ability as a cytotoxic agent against H. pylori, a scavenger of ROS and an inhibitor of NADPH oxidase in neutrophils. Octyl gallate, a widely used food additive, showed the highest antimicrobial activity against H. pylori, with a minimum inhibitory concentration (MIC) value of 125 µg mL-1, whereas gallic acid had a MIC value higher than 1000 µg mL-1. The production of superoxide anion radicals was almost 100% abolished by the addition of 10 µM (2.82 µg mL-1) octyl gallate, whereas gallic acid inhibited around 20%. A similar tendency was also found when measuring the production of hypochlorous acid. The protective effect of the esters was cytochemically confirmed. In conclusion, this study showed that hydrophobicity is a crucial factor to obtain a significant anti-ROS and anti-H. pylori activity. Finally, it highlights octyl gallate, a food additive widely used in the food industry, as a promising molecule in the treatment of H. pylori infection.


Asunto(s)
Aditivos Alimentarios/farmacología , Ácido Gálico/análogos & derivados , Infecciones por Helicobacter/microbiología , Helicobacter pylori/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Ácido Gálico/farmacología , Mucosa Gástrica/metabolismo , Mucosa Gástrica/microbiología , Infecciones por Helicobacter/tratamiento farmacológico , Infecciones por Helicobacter/enzimología , Infecciones por Helicobacter/metabolismo , Helicobacter pylori/crecimiento & desarrollo , Humanos , NADPH Oxidasas/antagonistas & inhibidores , NADPH Oxidasas/metabolismo , Neutrófilos/efectos de los fármacos , Neutrófilos/enzimología , Neutrófilos/metabolismo , Especies Reactivas de Oxígeno/metabolismo
2.
J Ethnopharmacol ; 174: 410-8, 2015 Nov 04.
Artículo en Inglés | MEDLINE | ID: mdl-26320685

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Garcinia brasiliensis, a plant native to the Brazilian Amazon Rainforest, is used in traditional medicine to treat inflammation of the urinary tract, peptic ulcers, arthritis and other conditions. AIM OF THE STUDY: The purposes of this study were to analyze the chemical constituents of G. brasiliensis branches and leaves and to evaluate the potential of isolated compounds to act as inhibitors of both the oxidative burst of stimulated neutrophils and oxidative damage in human erythrocyte membranes to verify the antioxidant and anti-inflammatory effects of this plant. MATERIALS AND METHODS: Neutrophils were isolated from the blood of healthy donors by Ficoll-Paque density gradient centrifugation. Superoxide anion and total reactive oxygen species (ROS) produced by stimulated neutrophils were measured by WST-1 reduction and luminol-enhanced chemiluminescence assays, respectively. Radical-induced lipoperoxidation and hemolysis were performed using erythrocytes from the blood of healthy donors. Compounds were isolated from G. brasiliensis branches and leaves by HPLC microfractionation, and structure elucidation of the isolated compounds was performed based on NMR and HR-MS analyses. RESULTS: The biflavonoids procyanidin, fukugetin, amentoflavone and podocarpusflavone isolated from G. brasiliensis showed potent inhibitory effects on the oxidative burst of human neutrophils, inhibiting ROS production by 50% at 1 µmol L(-1). These biflavonoids also proved to be potent inhibitors of hemolysis (with 88 ± 7% inhibition at 50 µmol L(-1) for procyanidin) and lipid peroxidation in human erythrocytes, with a malondialdehyde level (a biomarker of oxidative stress) of 8.5 ± 0.3 nmol/mg Hb at 50 µmol L(-1) for procyanidin. CONCLUSIONS: These findings indicate that the biflavonoids extracted from G. brasiliensis branches and leaves modulate oxidative stress via inhibition of NADPH oxidase and ROS production by stimulated human neutrophils. Furthermore, the biflavonoids exhibited potent inhibition of oxidant hemolysis and lipid peroxidation induced by AAPH in human erythrocytes. Therefore, these studies suggest the use of G. brasiliensis extract as an antioxidant and anti-inflammatory agent.


Asunto(s)
Membrana Eritrocítica/efectos de los fármacos , Flavonoides/farmacología , Garcinia/química , Neutrófilos/efectos de los fármacos , Neutrófilos/metabolismo , Estallido Respiratorio/efectos de los fármacos , Antiinflamatorios no Esteroideos/farmacología , Flavonoides/aislamiento & purificación , Hemólisis/efectos de los fármacos , Humanos , Técnicas In Vitro , Peroxidación de Lípido/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Fenoles/aislamiento & purificación , Fenoles/farmacología , Hojas de la Planta/química , Especies Reactivas de Oxígeno/metabolismo , Superóxidos/metabolismo
3.
Mem. Inst. Oswaldo Cruz ; 110(4): 534-542, 09/06/2015. graf
Artículo en Inglés | LILACS | ID: lil-748872

RESUMEN

Hepatitis C virus (HCV) envelope protein 2 (E2) is involved in viral binding to host cells. The aim of this work was to produce recombinant E2B and E2Y HCV proteins in Escherichia coli and Pichia pastoris, respectively, and to study their interactions with low-density lipoprotein receptor (LDLr) and CD81 in human umbilical vein endothelial cells (HUVEC) and the ECV304 bladder carcinoma cell line. To investigate the effects of human LDL and differences in protein structure (glycosylated or not) on binding efficiency, the recombinant proteins were either associated or not associated with lipoproteins before being assayed. The immunoreactivity of the recombinant proteins was analysed using pooled serum samples that were either positive or negative for hepatitis C. The cells were immunophenotyped by LDLr and CD81 using flow cytometry. Binding and binding inhibition assays were performed in the presence of LDL, foetal bovine serum (FCS) and specific antibodies. The results revealed that binding was reduced in the absence of FCS, but that the addition of human LDL rescued and increased binding capacity. In HUVEC cells, the use of antibodies to block LDLr led to a significant reduction in the binding of E2B and E2Y. CD81 antibodies did not affect E2B and E2Y binding. In ECV304 cells, blocking LDLr and CD81 produced similar effects, but they were not as marked as those that were observed in HUVEC cells. In conclusion, recombinant HCV E2 is dependent on LDL for its ability to bind to LDLr in HUVEC and ECV304 cells. These findings are relevant because E2 acts to anchor HCV to host cells; therefore, high blood levels of LDL could enhance viral infectivity in chronic hepatitis C patients.


Asunto(s)
Animales , Bovinos , Humanos , /fisiología , Células Endoteliales/virología , Hepacivirus/inmunología , Receptores de LDL/fisiología , Proteínas del Envoltorio Viral/fisiología , /inmunología , Línea Celular , Escherichia coli , Células Endoteliales/inmunología , Citometría de Flujo , Proteínas de la Membrana , Pichia , Proteínas Recombinantes , Receptores de LDL/inmunología
4.
Mem Inst Oswaldo Cruz ; 110(4): 534-42, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-26018451

RESUMEN

Hepatitis C virus (HCV) envelope protein 2 (E2) is involved in viral binding to host cells. The aim of this work was to produce recombinant E2B and E2Y HCV proteins in Escherichia coli and Pichia pastoris, respectively, and to study their interactions with low-density lipoprotein receptor (LDLr) and CD81 in human umbilical vein endothelial cells (HUVEC) and the ECV304 bladder carcinoma cell line. To investigate the effects of human LDL and differences in protein structure (glycosylated or not) on binding efficiency, the recombinant proteins were either associated or not associated with lipoproteins before being assayed. The immunoreactivity of the recombinant proteins was analysed using pooled serum samples that were either positive or negative for hepatitis C. The cells were immunophenotyped by LDLr and CD81 using flow cytometry. Binding and binding inhibition assays were performed in the presence of LDL, foetal bovine serum (FCS) and specific antibodies. The results revealed that binding was reduced in the absence of FCS, but that the addition of human LDL rescued and increased binding capacity. In HUVEC cells, the use of antibodies to block LDLr led to a significant reduction in the binding of E2B and E2Y. CD81 antibodies did not affect E2B and E2Y binding. In ECV304 cells, blocking LDLr and CD81 produced similar effects, but they were not as marked as those that were observed in HUVEC cells. In conclusion, recombinant HCV E2 is dependent on LDL for its ability to bind to LDLr in HUVEC and ECV304 cells. These findings are relevant because E2 acts to anchor HCV to host cells; therefore, high blood levels of LDL could enhance viral infectivity in chronic hepatitis C patients.


Asunto(s)
Células Endoteliales/virología , Hepacivirus/inmunología , Receptores de LDL/fisiología , Tetraspanina 28/fisiología , Proteínas del Envoltorio Viral/fisiología , Animales , Bovinos , Línea Celular , Células Endoteliales/inmunología , Escherichia coli , Citometría de Flujo , Humanos , Proteínas de la Membrana , Pichia , Receptores de LDL/inmunología , Proteínas Recombinantes , Tetraspanina 28/inmunología
5.
Food Funct ; 6(6): 1818-31, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25927268

RESUMEN

Nordihydroguaiaretic acid (NDGA) and rosmarinic acid (RA), phenolic compounds found in various plants and functional foods, have known antioxidant and anti-inflammatory properties. In the present study, we comparatively investigated the importance of hydrophobicity and oxidisability of NDGA and RA, regarding their antioxidant and pharmacological activities. Using a panel of cell-free antioxidant protocols, including electrochemical measurements, we demonstrated that the anti-radical capacities of RA and NDGA were similar. However, the relative capacity of NDGA as an inhibitor of NADPH oxidase (ex vivo assays) was significantly higher compared to RA. The inhibitory effect on NADPH oxidase was not related to simple scavengers of superoxide anions, as confirmed by oxygen consumption by the activated neutrophils. The higher hydrophobicity of NDGA was also a determinant for the higher efficacy of NDGA regarding the inhibition of the release of hypochlorous acid by PMA-activated neutrophil and cytokine (TNF-α and IL-10) production by Staphylococcus aureus-stimulated peripheral blood mononuclear cells. In conclusion, although there have been extensive studies about the pharmacological properties of NDGA, our study showed, for the first time, the importance not only of its antioxidant activity, but also its hydrophobicity as a crucial factor for pharmacological action.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Antioxidantes/farmacología , Inhibidores Enzimáticos/farmacología , Leucocitos Mononucleares/efectos de los fármacos , Masoprocol/farmacología , NADPH Oxidasas/antagonistas & inhibidores , Neutrófilos/efectos de los fármacos , Adulto , Antiinflamatorios no Esteroideos/efectos adversos , Antiinflamatorios no Esteroideos/química , Antioxidantes/efectos adversos , Antioxidantes/química , Células Cultivadas , Cinamatos/efectos adversos , Cinamatos/química , Cinamatos/farmacología , Citocinas/antagonistas & inhibidores , Citocinas/metabolismo , Depsidos/efectos adversos , Depsidos/química , Depsidos/farmacología , Inhibidores Enzimáticos/efectos adversos , Inhibidores Enzimáticos/química , Fármacos Hematológicos/efectos adversos , Fármacos Hematológicos/química , Fármacos Hematológicos/farmacología , Hemólisis/efectos de los fármacos , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Ácido Hipocloroso/antagonistas & inhibidores , Ácido Hipocloroso/metabolismo , Leucocitos Mononucleares/citología , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Activación de Linfocitos/efectos de los fármacos , Masoprocol/efectos adversos , Masoprocol/química , NADPH Oxidasas/metabolismo , Activación Neutrófila/efectos de los fármacos , Neutrófilos/citología , Neutrófilos/inmunología , Neutrófilos/metabolismo , Concentración Osmolar , Adulto Joven , Ácido Rosmarínico
6.
PLoS One ; 9(10): e110277, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25340774

RESUMEN

Pro-oxidant effects of phenolic compounds are usually correlated to the one-electron redox potential of the phenoxyl radicals. Here we demonstrated that, besides their oxidizability, hydrophobicity can also be a decisive factor. We found that esterification of protocatechuic acid (P0) provoked a profound influence in its pro-oxidant capacity. The esters bearing alkyl chains containing two (P2), four (P4) and seven (P7) carbons, but not the acid precursor (P0), were able to exacerbate the oxidation of trolox, α-tocopherol and rifampicin. This effect was also dependent on the catechol moiety, since neither gallic acid nor butyl gallate showed any pro-oxidant effects. A comparison was also made with apocynin, which is well-characterized regarding its pro-oxidant properties. P7 was more efficient than apocynin regarding co-oxidation of trolox. However, P7 was not able to co-oxidize glutathione and NADH, which are targets of the apocynin radical. A correlation was found between pro-oxidant capacity and the stability of the radicals, as suggested by the intensity of the peak current in the differential pulse voltammetry experiments. In conclusion, taking into account that hydroquinone and related moieties are frequently found in biomolecules and quinone-based chemotherapeutics, our demonstration that esters of protocatechuic acid are specific and potent co-catalysts in their oxidations may be very relevant as a pathway to exacerbate redox cycling reactions, which are usually involved in their biological and pharmacological mechanisms of action.


Asunto(s)
Hidroxibenzoatos/farmacología , Oxidantes/farmacología , Acetofenonas/química , Acetofenonas/metabolismo , Antioxidantes/farmacología , Cromanos , Técnicas Electroquímicas , Esterificación , Glutatión/metabolismo , Concentración de Iones de Hidrógeno , Interacciones Hidrofóbicas e Hidrofílicas/efectos de los fármacos , Hidroxibenzoatos/química , Hidroxilación/efectos de los fármacos , Cinética , Redes y Vías Metabólicas/efectos de los fármacos , NAD/metabolismo , Oxidación-Reducción/efectos de los fármacos , Rifampin/farmacología , alfa-Tocoferol/farmacología
7.
Mem Inst Oswaldo Cruz ; 109(6): 748-56, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25317702

RESUMEN

The hepatitis C virus (HCV) encodes approximately 10 different structural and non-structural proteins, including the envelope glycoprotein 2 (E2). HCV proteins, especially the envelope proteins, bind to cell receptors and can damage tissues. Endothelial inflammation is the most important determinant of fibrosis progression and, consequently, cirrhosis. The aim of this study was to evaluate and compare the inflammatory response of endothelial cells to two recombinant forms of the HCV E2 protein produced in different expression systems (Escherichia coli and Pichia pastoris). We observed the induction of cell death and the production of nitric oxide, hydrogen peroxide, interleukin-8 and vascular endothelial growth factor A in human umbilical vein endothelial cells (HUVECs) stimulated by the two recombinant E2 proteins. The E2-induced apoptosis of HUVECs was confirmed using the molecular marker PARP. The apoptosis rescue observed when the antioxidant N-acetylcysteine was used suggests that reactive oxygen species are involved in E2-induced apoptosis. We propose that these proteins are involved in the chronic inflammation caused by HCV.


Asunto(s)
Hepacivirus/metabolismo , Células Endoteliales de la Vena Umbilical Humana/inmunología , Células Endoteliales de la Vena Umbilical Humana/patología , Óxido Nítrico/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Proteínas del Envoltorio Viral/metabolismo , Apoptosis/genética , Arginasa/metabolismo , Supervivencia Celular , Escherichia coli/metabolismo , Fibrosis , Expresión Génica/genética , Ingeniería Genética/métodos , Vectores Genéticos/metabolismo , Hepacivirus/inmunología , Antígenos de la Hepatitis C/metabolismo , Humanos , Inflamación/metabolismo , Interleucina-8/metabolismo , Pichia/metabolismo , Plásmidos/metabolismo , Proteínas Recombinantes , Factor A de Crecimiento Endotelial Vascular/metabolismo
8.
Artículo en Inglés | MEDLINE | ID: mdl-25254058

RESUMEN

Numerous anti-inflammatory properties have been attributed to caffeic acid phenethyl ester (CAPE), an active component of propolis. NADPH oxidases are multienzymatic complexes involved in many inflammatory diseases. Here, we studied the importance of the CAPE hydrophobicity on cell-free antioxidant capacity, inhibition of the NADPH oxidase and hypochlorous acid production, and release of TNF-α and IL-10 by activated leukocytes. The comparison was made with the related, but less hydrophobic, caffeic and chlorogenic acids. Cell-free studies such as superoxide anion scavenging assay, triene degradation, and anodic peak potential (E pa) measurements showed that the alterations in the hydrophobicity did not provoke significant changes in the oxidation potential and antiradical potency of the tested compounds. However, only CAPE was able to inhibit the production of superoxide anion by activated leukocytes. The inhibition of the NADPH oxidase resulted in the blockage of production of hypochlorous acid. Similarly, CAPE was the more effective inhibitor of the release of TNF-α and IL-10 by Staphylococcus aureus stimulated cells. In conclusion, the presence of the catechol moiety and the higher hydrophobicity were essential for the biological effects. Considering the involvement of NADPH oxidases in the genesis and progression of inflammatory diseases, CAPE should be considered as a promising anti-inflammatory drug.

9.
Mem. Inst. Oswaldo Cruz ; 109(6): 748-756, 09/09/2014. graf
Artículo en Inglés | LILACS | ID: lil-723994

RESUMEN

The hepatitis C virus (HCV) encodes approximately 10 different structural and non-structural proteins, including the envelope glycoprotein 2 (E2). HCV proteins, especially the envelope proteins, bind to cell receptors and can damage tissues. Endothelial inflammation is the most important determinant of fibrosis progression and, consequently, cirrhosis. The aim of this study was to evaluate and compare the inflammatory response of endothelial cells to two recombinant forms of the HCV E2 protein produced in different expression systems (Escherichia coli and Pichia pastoris). We observed the induction of cell death and the production of nitric oxide, hydrogen peroxide, interleukin-8 and vascular endothelial growth factor A in human umbilical vein endothelial cells (HUVECs) stimulated by the two recombinant E2 proteins. The E2-induced apoptosis of HUVECs was confirmed using the molecular marker PARP. The apoptosis rescue observed when the antioxidant N-acetylcysteine was used suggests that reactive oxygen species are involved in E2-induced apoptosis. We propose that these proteins are involved in the chronic inflammation caused by HCV.


Asunto(s)
Humanos , Hepacivirus/metabolismo , Células Endoteliales de la Vena Umbilical Humana/inmunología , Células Endoteliales de la Vena Umbilical Humana/patología , Óxido Nítrico/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Proteínas del Envoltorio Viral/metabolismo , Apoptosis/genética , Arginasa/metabolismo , Supervivencia Celular , Escherichia coli/metabolismo , Fibrosis , Expresión Génica/genética , Ingeniería Genética/métodos , Vectores Genéticos/metabolismo , Hepacivirus/inmunología , Antígenos de la Hepatitis C/metabolismo , Inflamación/metabolismo , /metabolismo , Pichia/metabolismo , Plásmidos/metabolismo , Proteínas Recombinantes , Factor A de Crecimiento Endotelial Vascular/metabolismo
10.
PLoS One ; 9(8): e105217, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25133630

RESUMEN

Plasmodium vivax is the most prevalent of the five species causing malaria in humans. The current available treatment for P. vivax malaria is limited and unsatisfactory due to at least two drawbacks: the undesirable side effects of primaquine (PQ) and drug resistance to chloroquine. Phenylalanine-alanine-PQ (Phe-Ala-PQ) is a PQ prodrug with a more favorable pharmacokinetic profile compared to PQ. The toxicity of this prodrug was evaluated in in vitro assays using a human hepatoma cell line (HepG2), a monkey kidney cell line (BGM), and human red blood cells deficient in the enzyme glucose-6-phosphate-dehydrogenase (G6PD). In addition, in vivo toxicity assays were performed with rats that received multiple doses of Phe-Ala-PQ to evaluate biochemical, hematological, and histopathological parameters. The activity was assessed by the inhibition of the sporogonic cycle using a chicken malaria parasite. Phe-Ala-PQ blocked malaria transmission in Aedes mosquitoes. When compared with PQ, it was less cytotoxic to BGM and HepG2 cells and caused less hemolysis of G6PD-deficient red blood cells at similar concentrations. The prodrug caused less alteration in the biochemical parameters than did PQ. Histopathological analysis of the liver and kidney did show differences between the control and Phe-Ala-PQ-treated groups, but they were not statistically significant. Taken together, the results highlight the prodrug as a novel lead compound candidate for the treatment of P. vivax malaria and as a blocker of malaria transmission.


Asunto(s)
Antimaláricos/efectos adversos , Antimaláricos/uso terapéutico , Profármacos/efectos adversos , Profármacos/uso terapéutico , Aedes/parasitología , Animales , Antimaláricos/farmacología , Línea Celular , Cloroquina/efectos adversos , Cloroquina/farmacología , Cloroquina/uso terapéutico , Dipéptidos/efectos adversos , Dipéptidos/farmacología , Dipéptidos/uso terapéutico , Glucosafosfato Deshidrogenasa/metabolismo , Hemólisis/efectos de los fármacos , Células Hep G2 , Humanos , Malaria Vivax/tratamiento farmacológico , Masculino , Plasmodium gallinaceum/efectos de los fármacos , Plasmodium vivax/efectos de los fármacos , Primaquina/efectos adversos , Primaquina/análogos & derivados , Primaquina/farmacología , Primaquina/uso terapéutico , Profármacos/farmacología , Ratas , Ratas Wistar
11.
Hum Immunol ; 75(8): 785-90, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24945596

RESUMEN

Considering that human neutrophil FcγRIIa and FcγRIIIb receptors interact synergistically with CR3 in triggering neutrophil functional responses, allelic polymorphisms in these receptors might influence such interactions. We assessed whether FcγRIIIb polymorphisms affect FcγR/CR cooperation in mediating the neutrophil oxidative burst (OB), in particular the FcγRIIIb/CR3 cooperation that occurs via lectin-saccharide-like interactions. The OB of human neutrophil antigen (HNA)-1a-, HNA-1b-, and HNA-1a/-1b-neutrophils stimulated with immune complexes, opsonized or not with serum complement, was measured by the luminol-enhanced chemiluminescence assay. Compared with HNA-1a-neutrophils, HNA-1b-neutrophils exhibited reduced FcγR-stimulated OB, but increased FcγR/CR-stimulated OB. It suggests that (i) FcγR and CR cooperate more effectively in HNA-1b-neutrophils, and (ii) the HNA-1b allotype influences the FcγRIIIb cooperation with FcγRIIa, but not with CR3. HNA-1a- and HNA-1b-neutrophils exhibited similar OB responses elicited via CR3 alone or via FcγR/CR-independent pathways. In addition, the level of FcγRIIIb, FcγRIIa, and CR3 expression did not differ significantly among the neutrophil groups studied. Together, these results demonstrate that the HNA-1b allotype influences the functional cooperation between FcγRIIIb and FcγRIIa, and suggest that the difference in the glycosylation pattern between HNA-1a and HNA-1b does not affect the FcγRIIIb cooperation with CR3.


Asunto(s)
Antígeno de Macrófago-1/genética , Neutrófilos/inmunología , Receptores de IgG/genética , Estallido Respiratorio/inmunología , Adulto , Complejo Antígeno-Anticuerpo/farmacología , Proteínas del Sistema Complemento/farmacología , Femenino , Proteínas Ligadas a GPI/genética , Proteínas Ligadas a GPI/inmunología , Regulación de la Expresión Génica , Haplotipos , Humanos , Isoantígenos/genética , Isoantígenos/inmunología , Antígeno de Macrófago-1/inmunología , Masculino , Neutrófilos/citología , Neutrófilos/efectos de los fármacos , Polimorfismo Genético , Cultivo Primario de Células , Receptor Cross-Talk/inmunología , Receptores de IgG/inmunología , Estallido Respiratorio/efectos de los fármacos , Estallido Respiratorio/genética , Transducción de Señal
12.
Molecules ; 19(5): 6597-608, 2014 May 22.
Artículo en Inglés | MEDLINE | ID: mdl-24858094

RESUMEN

Chemical investigation of an acetonitrile fraction from the endophytic fungus Phomopsis sp. led to the isolation of the new natural product 2-hydroxy-alternariol (7) together with the known compounds cytochalasins J (1) and H (2), 5'-epialtenuene (3) and the mycotoxins alternariol monomethyl ether (AME, 4), alternariol (AOH, 5) and cytosporone C (6). The structure of the new compound was elucidated by using 1-D and 2-D NMR (nuclear magnetic resonance) and high resolution mass spectrometry. The cytochalasins J (1) and H (2) and AOH (5) exhibited potent inhibition of the total ROS (reactive oxygen species) produced by stimulated human neutrophils and acted as potent potential anti-inflammatory agents. Moreover, cytochalasin H (2) demonstrated antifungal and acetylcholinesterase enzyme (AChE) inhibition in vitro.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Antifúngicos/farmacología , Ascomicetos/metabolismo , Antiinflamatorios no Esteroideos/química , Antifúngicos/química , Antioxidantes/química , Antioxidantes/farmacología , Ascomicetos/química , Inhibidores de la Colinesterasa/química , Inhibidores de la Colinesterasa/farmacología , Citocalasinas/química , Citocalasinas/farmacología , Evaluación Preclínica de Medicamentos/métodos , Endófitos/metabolismo , Humanos , Lactonas , Espectroscopía de Resonancia Magnética , Estructura Molecular , Micotoxinas/química , Micotoxinas/metabolismo , Neutrófilos/efectos de los fármacos , Neutrófilos/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Metabolismo Secundario , Senna/microbiología , Sesquiterpenos/química , Sesquiterpenos/farmacología
13.
Med Chem ; 10(1): 74-80, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-23628087

RESUMEN

Helicobacter pylori pathogenic action involves the colonization of the gastrointestinal tract and a large production of reactive oxygen species (ROS) by the neutrophils attracted to the site of infection. The aim of this study was to evaluate caffeic acid and its alkyl esters as inhibitors of the release of ROS by Helicobacter pylori activated neutrophils and their bactericidal effect. The increased hydrophobicity caused by esterification had direct consequence in their efficiency as bactericidal agents against H. pylori and inhibitors of the production of ROS by neutrophils. The minimum inhibitory concentration (MIC) decreased from higher than 1000 µg/mL (caffeic acid) to 250 µg/mL to butyl and heptyl caffeate. The release of total ROS, superoxide anion and hypochlorous acid by activated neutrophils was also significantly decreased and the esters were more efficient than the acid precursor. In conclusion, the alkyl esters of caffeic acid have two properties that are complementary for the treatment of H. pylori infections: bactericidal activity and inhibitory effect upon generation of ROS by neutrophils. Hence, we propose that these easily synthesized and non-expensive substances should be applied to in vivo experimental models of H. pylori induced gastric infections.


Asunto(s)
Antibacterianos/farmacología , Ácidos Cafeicos/farmacología , Helicobacter pylori/efectos de los fármacos , Neutrófilos/metabolismo , Especies Reactivas de Oxígeno/antagonistas & inhibidores , Alquilación , Antibacterianos/síntesis química , Antibacterianos/química , Humanos , Pruebas de Sensibilidad Microbiana , Especies Reactivas de Oxígeno/metabolismo
14.
Artículo en Inglés | MEDLINE | ID: mdl-23970939

RESUMEN

Ten Brazilian medicinal plants used to treat gastritis and ulcers were carefully selected on the basis of ethnopharmacological importance and antiulcerogenic activity previously described. The antioxidant activity of the methanolic extracts was determined in analysis conditions that simulate a real biological activity on inhibition of the oxidative burst induced in neutrophils using Helicobacter pylori as activator, by a luminol-amplified chemiluminescence assay. The extracts, at low concentration (5 µ g/mL), exhibited a large variation in inhibitory effects of H. pylori-induced oxidative burst ranging from 48% inhibition to inactive, but all extracts, excluding Byrsonima intermedia, had inhibitory activity over 80% at the concentration of 100 µ g/mL. The total suppressive antioxidant capacity measured as the effective concentration, which represents the extract concentration producing 50% inhibition of the chemiluminescence induced by H. pylori, varies from 27.2 to 56.8 µ g/mL and was in the following order: Qualea parviflora > Qualea multiflora > Alchornea triplinervia > Qualea grandiflora > Anacardium humile > Davilla elliptica > Mouriri pusa > Byrsonima basiloba > Alchornea glandulosa > Byrsonima intermedia. The main groups of compounds in tested extracts are presented. Differences in the phytochemical profile, quantitatively and qualitatively, of these plants can explain and justify their protective effect on the gastric mucosa caused by the neutrophil-generated ROS that occurs when H. pylori displays its evasion mechanisms.

15.
Molecules ; 18(3): 2821-39, 2013 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-23455672

RESUMEN

Apocynin is the most employed inhibitor of NADPH oxidase (NOX), a multienzymatic complex capable of catalyzing the one-electron reduction of molecular oxygen to the superoxide anion. Despite controversies about its selectivity, apocynin has been used as one of the most promising drugs in experimental models of inflammatory and neurodegenerative diseases. Here, we aimed to study the chemical and biophysical properties of apocynin. The oxidation potential was determined by cyclic voltammetry (Epa = 0.76V), the hydrophobicity index was calculated (logP = 0.83) and the molar absorption coefficient was determined (e275nm = 1.1 × 104 M-1 cm-1). Apocynin was a weak free radical scavenger (as measured using the DPPH, peroxyl radical and nitric oxide assays) when compared to protocatechuic acid, used here as a reference antioxidant. On the other hand, apocynin was more effective than protocatechuic acid as scavenger of the non-radical species hypochlorous acid. Apocynin reacted promptly with the non-radical reactive species H2O2 only in the presence of peroxidase. This finding is relevant, since it represents a new pathway for depleting H2O2 in cellular experimental models, besides the direct inhibition of NADPH oxidase. This could be relevant for its application as an inhibitor of NOX4, since this isoform produces H2O2 and not superoxide anion. The binding parameters calculated by fluorescence quenching showed that apocynin binds to human serum albumin (HSA) with a binding affinity of 2.19 × 104 M-1. The association did not alter the secondary and tertiary structure of HSA, as verified by synchronous fluorescence and circular dichroism. The displacement of fluorescent probes suggested that apocynin binds to site I and site II of HSA. Considering the current biomedical applications of this phytochemical, the dissemination of these chemical and biophysical properties can be very helpful for scientists and physicians interested in the use of apocynin.


Asunto(s)
Acetofenonas/química , Acetofenonas/farmacología , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , NADPH Oxidasas/antagonistas & inhibidores , Depuradores de Radicales Libres/química , Depuradores de Radicales Libres/farmacología , Peróxido de Hidrógeno/antagonistas & inhibidores , Peróxido de Hidrógeno/química , Concentración de Iones de Hidrógeno , Interacciones Hidrofóbicas e Hidrofílicas , Ácido Hipocloroso/antagonistas & inhibidores , Ácido Hipocloroso/química , Cinética , Oxidación-Reducción
16.
Biopharm Drug Dispos ; 33(8): 437-45, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22899089

RESUMEN

Primaquine is an important therapeutic resource for malaria treatment and it has wide activity against several pathogens. The haematotoxicity of primaquine is the major problem for its therapeutic application. This effect is aggravated by repeated use at high doses and by the wide fluctuation of plasma levels after administration. The primaquine prodrug (Phe-Ala-PQ) was planned in order to modify the pharmacokinetics and toxicity of primaquine. The in vitro conversion of Phe-Ala-PQ to primaquine, and the primaquine pharmacokinetics were evaluated in four groups of rats: two groups that received a single dose of Phe-Ala-PQ, one by intravenous and the other by gavage route, and two other groups that received primaquine diphosphate, by intravenous and gavage routes. In addition, the erythrocyte osmotic fragility was compared in two groups of rats that received multiple doses of primaquine diphosphate or Phe-Ala-PQ, as a parameter of haematotoxicity. The in vitro conversion of Phe-Ala-PQ to primaquine by plasma enzyme action was observed. The pharmacokinetic profile of primaquine from Phe-Ala-PQ was more favourable due to the lower fluctuation of plasma concentrations. Haematotoxicity was not evidenced in the prodrug administration. The results reinforce the need for further studies with this prodrug, promising an alternative in the therapeutic use of primaquine.


Asunto(s)
Antimaláricos/farmacocinética , Dipéptidos/farmacocinética , Eritrocitos/efectos de los fármacos , Primaquina/farmacocinética , Profármacos/administración & dosificación , Administración Intravenosa , Administración Oral , Animales , Antimaláricos/administración & dosificación , Antimaláricos/sangre , Dipéptidos/administración & dosificación , Dipéptidos/sangre , Dipéptidos/química , Estabilidad de Medicamentos , Eritrocitos/fisiología , Masculino , Primaquina/administración & dosificación , Primaquina/análogos & derivados , Primaquina/sangre , Profármacos/química , Ratas , Ratas Wistar
17.
Int J Mol Sci ; 13(1): 133-41, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22312243

RESUMEN

Byrsonima crassa Niedenzu (Malpighiaceae) is used in Brazilian folk medicine for the treatment of diseases related mainly to gastric ulcers. In a previous study, our group described the gastric protective effect of the methanolic extract from the leaves of B. crassa. The present study was carried out to investigate the effects of methanolic extract and its phenolic compounds on the respiratory burst of neutrophils stimulated by H. pylori using a luminol-based chemiluminescence assay as well as their anti-H. pylori activity. The suppressive activity on oxidative burst of H. pylori-stimulated neutrophils was in the order of methyl gallate > (+)-catechin > methanol extract > quercetin 3-O-α-l-arabinopyranoside > quercetin 3-O-ß-d-galactopyranoside > amentoflavone. Methyl gallate, compound that induced the highest suppressive activity with IC(50) value of 3.4 µg/mL, did not show anti-H. pylori activity. B. crassa could be considered as a potential source of natural antioxidant in gastric ulcers by attenuating the effects on the damage to gastric mucosa caused by neutrophil generated reactive oxygen species, even when H. pylori displays its evasion mechanisms.


Asunto(s)
Antioxidantes/farmacología , Helicobacter pylori/patogenicidad , Malpighiaceae/química , Fenoles/farmacología , Estallido Respiratorio/efectos de los fármacos , Antioxidantes/química , Ácido Gálico/análogos & derivados , Ácido Gálico/química , Ácido Gálico/aislamiento & purificación , Ácido Gálico/farmacología , Mucosa Gástrica/citología , Mucosa Gástrica/microbiología , Mucosa Gástrica/patología , Helicobacter pylori/efectos de los fármacos , Malpighiaceae/metabolismo , Metanol/química , Neutrófilos/inmunología , Neutrófilos/microbiología , Fenoles/química , Fenoles/aislamiento & purificación , Extractos Vegetales/química , Hojas de la Planta/química , Hojas de la Planta/metabolismo , Especies Reactivas de Oxígeno/metabolismo
18.
Rev. bras. farmacogn ; 22(1): 53-59, Jan.-Feb. 2012. ilus, graf, tab
Artículo en Inglés | LILACS | ID: lil-607601

RESUMEN

Helicobacter pylori is a bacterium recognized as the major cause of chronic gastritis and peptic ulcers. Infection by H. pylori induces inflammatory responses and pathological changes in the gastric microenvironment. The host Keywords: immune cells (especially neutrophils) release inflammatory mediators and large 5-methoxy-3,4-dehydroxanthomegnin amounts of reactive oxygen species (ROS), which are associated with an increased Helicobacter pyloririsk of developing gastric cancer. In this study, we evaluated the anti-H. pylori and oxidative burst antioxidantactivitiesofa1,4-naphthoquinone-5-methoxy-3,4-dehydroxanthomegnin. Paepalanthus latipes The antimicrobial activity was assessed using a spectrophotometric microdilution technique, and antioxidant activity was assessed by noting the effect of 5-methoxy3,4-dehydroxanthomegnin on the neutrophil oxidative burst using luminol-and lucigenin-amplified chemiluminescence. The results showed that 5-methoxy-3,4dehydroxanthomegnin is a potent anti-H. pylori compound (MIC 64 µg/mL and MBC 128 µg/mL) and a strong antioxidant. 5-Methoxy-3,4-dehydroxanthomegnin decreased luminol- and lucigenin-amplified chemiluminescence, with ED50 values of 1.58±0.09 µg/mL and 5.4±0.15 µg/mL, respectively, reflecting an inhibitory effect on the oxidative burst. These results indicate that 5-methoxy-3,4-dehydroxanthomegnin is a promising compound for the prevention and treatment of diseases caused by H. pylori infection, such as gastritis, peptic ulceration, and gastric cancer, because reactive oxygen intermediates are involved in the pathogenesis of gastric mucosal injury induced by H. pylori infections.

19.
Arch Biochem Biophys ; 507(2): 315-22, 2011 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-21187060

RESUMEN

Taurine is the most abundant free amino acid in leukocytes and can react with HOBr to produce taurine bromamine (Tau-NHBr). The aim of this study was to assess the ability of Tau-NHBr to oxidize tryptophan, either free or as a residue in albumin. We have demonstrated that Tau-NHBr is a powerful oxidant for tryptophan. Importantly, in comparison to taurine chloramine, HOCl or HOBr, Tau-NHBr exhibits a degree of selectivity for tryptophan. Oxidation of albumin by Tau-NHBr resulted in emission of light, and the quantum yield was more than 10-fold more efficient than that of the other oxidants. The fluorescence band corresponding to oxidized albumin (λ(ex) 350/λ(em) 450), which is characteristic of the formation of formylkynurenine, was significantly higher in reactions using Tau-NHBr. Excitation of the fluorescent probe 8-anilino-1-naphthalenesulfonate at 295 nm was used to assess the depletion of tryptophan residues in albumin. Results from this experiment further supported a higher efficiency of oxidation of tryptophan residues by Tau-NHBr. Other parameters of protein oxidation, including cysteine depletion and formation of carbonyl groups, were not significantly different between the oxidants tested. In conclusion, these results indicate that Tau-NHBr has a higher affinity for tryptophan residues in proteins.


Asunto(s)
Oxidantes/farmacología , Albúmina Sérica/química , Albúmina Sérica/metabolismo , Taurina/análogos & derivados , Triptófano/metabolismo , Animales , Bromatos/farmacología , Bovinos , Humanos , Oxidación-Reducción/efectos de los fármacos , Especificidad por Sustrato , Taurina/farmacología
20.
Appl. cancer res ; 30(1): 204-209, Jan.-Mar. 2010. ilus
Artículo en Inglés | LILACS, Inca | ID: lil-547638

RESUMEN

The antibody-directed enzyme prodrug therapy (ADEPT) is a means of restricting the action of toxic drugs to the tumor site. The enzyme/prodrug pair horseradish peroxidase (HRP)/indole-3-acetic acid (IAA) has been studied as a combination with potential application in ADEPT strategies. In this combination, the non-toxic plant hormone IAA is activated to cytotoxic species by the catalytic action of HRP. Objective: We studied the use of the ethyl ester of IAA as a new prodrug that could be activated by two enzymes, HRP and esterase. Methods: The oxidation of IAA and its ethyl ester, catalyzed by HRP, was monitored by the consumption of dioxygen and liquid chromatography. The cytotoxicity of IAA and its ethyl ester in combination with HRP and esterase was assessed using the lineage McCoy cells through the trypan blue and neutral red assays. Results: We found that HRP was not able to catalyze the oxidation of IAA-ethyl ester in the absence of an additional esterase. Hence, the potential cytotoxicity of the IAA-ethyl ester could be controlled by sequential treatment with esterase, to liberate the carboxyl group, and HRP, for oxidation and generation of cytotoxic species. We present evidence for the potential application of the combination IAA-ethyl ester/esterase/horseradish peroxidase as a new ADEPT, GDEPT or related strategy. Conclusions: We suggest that this technique could provide more selectivity in the generation of cytotoxic drugs at tumor sites.


Asunto(s)
Esterasas , Peroxidasa de Rábano Silvestre , Protocolos de Quimioterapia Combinada Antineoplásica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA